158 related articles for article (PubMed ID: 16807445)
1. New target therapies in advanced pancreatic cancer.
Cascinu S; Verdecchia L; Valeri N; Berardi R; Scartozzi M
Ann Oncol; 2006 May; 17 Suppl 5():v148-52. PubMed ID: 16807445
[TBL] [Abstract][Full Text] [Related]
2. Molecular targeting therapy for pancreatic cancer.
Xiong HQ
Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S69-77. PubMed ID: 15316751
[TBL] [Abstract][Full Text] [Related]
3. Novel therapies for pancreatic adenocarcinoma.
Pino SM; Xiong HQ; McConkey D; Abbruzzese JL
Curr Oncol Rep; 2004 May; 6(3):199-206. PubMed ID: 15066231
[TBL] [Abstract][Full Text] [Related]
4. State of the Art for Metastatic Pancreatic Cancer Treatment: Where Are We Now?
Balsano R; Tommasi C; Garajova I
Anticancer Res; 2019 Jul; 39(7):3405-3412. PubMed ID: 31262862
[TBL] [Abstract][Full Text] [Related]
5. Molecularly targeted therapy for gastrointestinal cancer.
Wiedmann MW; Caca K
Curr Cancer Drug Targets; 2005 May; 5(3):171-93. PubMed ID: 15892618
[TBL] [Abstract][Full Text] [Related]
6. Molecular-targeted agents in pancreatic cancer.
Saad ED; Hoff PM
Cancer Control; 2004; 11(1):32-8. PubMed ID: 14749621
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor: is a novel therapeutic target for pancreatic cancer?
Dhar A; Mehta S; Banerjee S; Dhar K; Dhar G; Sengupta K; Ray G; Banerjee SK; Campbell DR
Front Biosci; 2005 May; 10():1763-7. PubMed ID: 15769665
[TBL] [Abstract][Full Text] [Related]
8. Novel approaches to target pancreatic cancer.
Porzner M; Seufferlein T
Curr Cancer Drug Targets; 2011 Jul; 11(6):698-713. PubMed ID: 21599630
[TBL] [Abstract][Full Text] [Related]
9. Advanced or metastatic pancreatic cancer: molecular targeted therapies.
Bayraktar S; Rocha-Lima CM
Mt Sinai J Med; 2010; 77(6):606-19. PubMed ID: 21105124
[TBL] [Abstract][Full Text] [Related]
10. Novel therapeutic approaches in the treatment of advanced pancreatic carcinoma.
Zalatnai A
Cancer Treat Rev; 2007 May; 33(3):289-98. PubMed ID: 17343986
[TBL] [Abstract][Full Text] [Related]
11. [Targeted therapies in thoracic oncology].
Quoix E; Beau-Faller M; Douillard JY; Milleron B
Rev Mal Respir; 2004 Jun; 21(3 Pt 1):527-37. PubMed ID: 15292845
[TBL] [Abstract][Full Text] [Related]
12. Current management of advanced non-small cell lung cancer: targeted therapy.
Isobe T; Herbst RS; Onn A
Semin Oncol; 2005 Jun; 32(3):315-28. PubMed ID: 15988686
[TBL] [Abstract][Full Text] [Related]
13. Recent development of molecular-targeted drugs in lung cancer.
Saijo N; Kenmotsu H
Intern Med; 2010; 49(18):1923-34. PubMed ID: 20847494
[TBL] [Abstract][Full Text] [Related]
14. Targeting signal transduction in pancreatic cancer treatment.
Yeh JJ; Der CJ
Expert Opin Ther Targets; 2007 May; 11(5):673-94. PubMed ID: 17465725
[TBL] [Abstract][Full Text] [Related]
15. EGFR as a potential target for the treatment of pancreatic cancer: dilemma and controversies.
Nedaeinia R; Avan A; Manian M; Salehi R; Ghayour-Mobarhan M
Curr Drug Targets; 2014; 15(14):1293-301. PubMed ID: 25429712
[TBL] [Abstract][Full Text] [Related]
16. Molecular and genetic bases of pancreatic cancer.
Vaccaro V; Gelibter A; Bria E; Iapicca P; Cappello P; Di Modugno F; Pino MS; Nuzzo C; Cognetti F; Novelli F; Nistico P; Milella M
Curr Drug Targets; 2012 Jun; 13(6):731-43. PubMed ID: 22458519
[TBL] [Abstract][Full Text] [Related]
17. Targeting EGFR in pancreatic cancer treatment.
Troiani T; Martinelli E; Capasso A; Morgillo F; Orditura M; De Vita F; Ciardiello F
Curr Drug Targets; 2012 Jun; 13(6):802-10. PubMed ID: 22458527
[TBL] [Abstract][Full Text] [Related]
18. Growth stimulation of COX-2-negative pancreatic cancer by a selective COX-2 inhibitor.
Eibl G; Takata Y; Boros LG; Liu J; Okada Y; Reber HA; Hines OJ
Cancer Res; 2005 Feb; 65(3):982-90. PubMed ID: 15705899
[TBL] [Abstract][Full Text] [Related]
19. Targeted therapies in non-small cell lung cancer: proven concepts and unfulfilled promises.
Auberger J; Loeffler-Ragg J; Wurzer W; Hilbe W
Curr Cancer Drug Targets; 2006 Jun; 6(4):271-94. PubMed ID: 16848720
[TBL] [Abstract][Full Text] [Related]
20. Recent advances on the molecular mechanisms involved in pancreatic cancer progression and therapies.
Mimeault M; Brand RE; Sasson AA; Batra SK
Pancreas; 2005 Nov; 31(4):301-16. PubMed ID: 16258363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
